INCREASED EXPRESSION OF MUTANT FORMS OF P53 ONCOGENE IN PRIMARY LUNG-CANCER

被引:1174
作者
IGGO, R
GATTER, K
BARTEK, J
LANE, D
HARRIS, AL
机构
[1] JOHN RADCLIFFE HOSP, INST MOLEC MED,IMPERIAL CANC RES FUND,ONCOL UNIT, MOLEC ONCOL LAB, OXFORD OX3 9DU, ENGLAND
[2] IMPERIAL CANC RES FUND, MOLEC IMMUNOCHEM LAB, POTTERS BAR, HERTS, ENGLAND
[3] RES INST CLIN & EXPTL ONCOL, BRNO, CZECHOSLOVAKIA
[4] UNIV OXFORD, DEPT PATHOL, OXFORD, ENGLAND
关键词
D O I
10.1016/0140-6736(90)90801-B
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary lung cancer samples of the major histological types were examined for expression of the tumour suppressor gene p53 by immunohistochemistry. Abnormalities in p53 expression were found in 28 of 40 carcinomas, 14 of 17 squamous tumours showing abnormal p53 expression, whereas no expression of p53 was detectable in 7 carcinoid tumours or in 10 normal lung samples. Direct evidence for homozygous expression of mutant p53 mRNA in representative carcinomas was obtained by means of an asymmetric polymerase chain reaction mRNA sequencing strategy, which allowed sequencing without any cloning step. All the mutations were G to Ttransversions resulting in mis-sense mutations in aminoacids highly conserved in evolution. Mutation of the p53 gene is the most frequently identified genetic change in human lung cancer; these findings suggest that simple immunohistological methods can provide strong evidence of such mutation. © 1990.
引用
收藏
页码:675 / 679
页数:5
相关论文
共 30 条
  • [1] Ausubel FM., 1988, CURRENT PROTOCOLS MO
  • [2] CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS
    BAKER, SJ
    FEARON, ER
    NIGRO, JM
    HAMILTON, SR
    PREISINGER, AC
    JESSUP, JM
    VANTUINEN, P
    LEDBETTER, DH
    BARKER, DF
    NAKAMURA, Y
    WHITE, R
    VOGELSTEIN, B
    [J]. SCIENCE, 1989, 244 (4901) : 217 - 221
  • [3] EPIDERMAL GROWTH-FACTOR RECEPTORS IN LUNG-TUMORS
    BERGER, MS
    GULLICK, WJ
    GREENFIELD, C
    EVANS, S
    ADDIS, BJ
    WATERFIELD, MD
    [J]. JOURNAL OF PATHOLOGY, 1987, 152 (04) : 297 - 307
  • [4] P53 EXPRESSION IN BREAST-CANCER
    CATTORETTI, G
    RILKE, F
    ANDREOLA, S
    DAMATO, L
    DELIA, D
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) : 178 - 183
  • [5] IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES)
    CORDELL, JL
    FALINI, B
    ERBER, WN
    GHOSH, AK
    ABDULAZIZ, Z
    MACDONALD, S
    PULFORD, KAF
    STEIN, H
    MASON, DY
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) : 219 - 229
  • [6] CELLULAR HETEROGENEITY IN LUNG-CANCER
    DUNNILL, MS
    GATTER, KC
    [J]. HISTOPATHOLOGY, 1986, 10 (05) : 461 - 475
  • [7] ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE
    FINLAY, CA
    HINDS, PW
    TAN, TH
    ELIYAHU, D
    OREN, M
    LEVINE, AJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) : 531 - 539
  • [8] THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION
    FINLAY, CA
    HINDS, PW
    LEVINE, AJ
    [J]. CELL, 1989, 57 (07) : 1083 - 1093
  • [9] PRODUCTION OF A MOUSE MONOCLONAL-ANTIBODY REACTIVE WITH A HUMAN NUCLEAR ANTIGEN ASSOCIATED WITH CELL-PROLIFERATION
    GERDES, J
    SCHWAB, U
    LEMKE, H
    STEIN, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (01) : 13 - 20
  • [10] GENERATION OF SINGLE-STRANDED-DNA BY THE POLYMERASE CHAIN-REACTION AND ITS APPLICATION TO DIRECT SEQUENCING OF THE HLA-DQA LOCUS
    GYLLENSTEN, UB
    ERLICH, HA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (20) : 7652 - 7656